Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Feb;68(2):227–230. doi: 10.1136/adc.68.2.227

A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis.

I M Bowler 1, S P Wolfe 1, H M Owens 1, T A Sheldon 1, J M Littlewood 1, M P Walters 1
PMCID: PMC1029241  PMID: 7683190

Abstract

A standard acid resistant microsphere pancreatic enzyme preparation was compared with identical capsules half filled with mini-tablets of a new high lipase preparation in a randomised double blind crossover study in children with cystic fibrosis. Each patient received his/her usual number of capsules and the same dose of lipase during each period of the study. Eighteen patients completed the study. There were fewer gastrointestinal symptoms when pancreatic enzyme was supplied as the high lipase preparation. There was also a significant improvement in fat absorption (17%, 95% confidence interval (CI) 6 to 27), reduction in faecal fat output (15.8 g/day, 95% CI 6.4 to 22.5), and faecal energy loss (789 kJ/day, 95% CI 211 to 1384). It is concluded that half filled capsules of the new high lipase preparation are more effective than the standard preparation and it is likely that filled capsules would allow patients to use fewer than half the number of pancreatic enzyme capsules.

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beverley D. W., Kelleher J., MacDonald A., Littlewood J. M., Robinson T., Walters M. P. Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child. 1987 Jun;62(6):564–568. doi: 10.1136/adc.62.6.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buchdahl R. M., Cox M., Fulleylove C., Marchant J. L., Tomkins A. M., Brueton M. J., Warner J. O. Increased resting energy expenditure in cystic fibrosis. J Appl Physiol (1985) 1988 May;64(5):1810–1816. doi: 10.1152/jappl.1988.64.5.1810. [DOI] [PubMed] [Google Scholar]
  3. Chrispin A. R., Norman A. P. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol. 1974;2(2):101–105. doi: 10.1007/BF01314939. [DOI] [PubMed] [Google Scholar]
  4. GIBSON L. E., COOKE R. E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959 Mar;23(3):545–549. [PubMed] [Google Scholar]
  5. Gaskin K., Gurwitz D., Durie P., Corey M., Levison H., Forstner G. Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr. 1982 Jun;100(6):857–862. doi: 10.1016/s0022-3476(82)80501-5. [DOI] [PubMed] [Google Scholar]
  6. Gilbert J., Kelleher J., Walters M. P., Littlewood J. M. Markers for faecal fat estimation in monitoring steatorrhoea in cystic fibrosis. Gut. 1988 Sep;29(9):1286–1288. doi: 10.1136/gut.29.9.1286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kraemer R., Rüdeberg A., Hadorn B., Rossi E. Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand. 1978 Jan;67(1):33–37. doi: 10.1111/j.1651-2227.1978.tb16273.x. [DOI] [PubMed] [Google Scholar]
  8. MacDonald A., Kelleher J., Littlewood J. M. A normal fat diet for cystic fibrosis: is a dietitian still needed? Scand J Gastroenterol Suppl. 1988;143:157–159. doi: 10.3109/00365528809090238. [DOI] [PubMed] [Google Scholar]
  9. Meyer J. H., Elashoff J., Porter-Fink V., Dressman J., Amidon G. L. Human postprandial gastric emptying of 1-3-millimeter spheres. Gastroenterology. 1988 Jun;94(6):1315–1325. doi: 10.1016/0016-5085(88)90669-5. [DOI] [PubMed] [Google Scholar]
  10. Morrison G., Morrison J., Redmond A., Byers C., McCracken K., Dodge J. A. Pancreatic enzyme supplements in cystic fibrosis. Lancet. 1991 Dec 21;338(8782-8783):1596–1597. doi: 10.1016/0140-6736(91)92421-w. [DOI] [PubMed] [Google Scholar]
  11. Murphy J. L., Wootton S. A., Bond S. A., Jackson A. A. Energy content of stools in normal healthy controls and patients with cystic fibrosis. Arch Dis Child. 1991 Apr;66(4):495–500. doi: 10.1136/adc.66.4.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Park R. W., Grand R. J. Gastrointestinal manifestations of cystic fibrosis: a review. Gastroenterology. 1981 Dec;81(6):1143–1161. [PubMed] [Google Scholar]
  13. Robinson P. J., Sly P. D. High dose pancreatic enzymes in cystic fibrosis. Arch Dis Child. 1990 Mar;65(3):311–312. doi: 10.1136/adc.65.3.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. SHWACHMAN H., KULCZYCKI L. L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child. 1958 Jul;96(1):6–15. doi: 10.1001/archpedi.1958.02060060008002. [DOI] [PubMed] [Google Scholar]
  15. Stead R. J., Skypala I., Hodson M. E., Batten J. C. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation. Thorax. 1987 Jul;42(7):533–537. doi: 10.1136/thx.42.7.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vaisman N., Pencharz P. B., Corey M., Canny G. J., Hahn E. Energy expenditure of patients with cystic fibrosis. J Pediatr. 1987 Oct;111(4):496–500. doi: 10.1016/s0022-3476(87)80107-5. [DOI] [PubMed] [Google Scholar]
  17. Vyas H., Matthew D. J., Milla P. J. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study. Eur J Pediatr. 1990 Jan;149(4):241–243. doi: 10.1007/BF02106281. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES